Skip to main content
Top

Hepatology International

Issue 5/2021

Content (22 Articles)

Hepatitis B Guidelines

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin-Lin Hou, Teerha Piratvisuth, Ji-Dong Jia, Masashi Mizokami, Gregory Cheng, Guo-Feng Chen, Zhen-Wen Liu, Oidov Baatarkhuu, Ann Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok, Jer-Ming Chang, Saeed Hamid, A. Kadir Dokmeci, Rino A. Gani, Diana A. Payawal, Pierce Chow, Joong-Won Park, Simone I. Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tanwandee Tawesak, Shiv Kumar Sarin, Masao Omata

Editorial

Connection between HPS and ACLF: a solution of chaos?

Hitoshi Maruyama, Shuichiro Shiina

Hepatitis B Original Article

Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B

Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park

Hepatitis B Original Article

Diabetes is associated with poor short-term prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure

Han Hu, Xinxin Hu, Caiyun Tian, Yanping Zhu, Yujuan Liu, Qijiao Cheng, Fangwan Yang, Jun Liu, Ying Li, Shide Lin

Hepatitis B Original Article

Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load

Baijun Li, Zhaozhe Liu, Xing Liu, Dongchun Liu, Mingyu Duan, Ye Gu, Qiong Liu, Qiang Ma, Yushi Wei, Yan Wang

Hepatitis B Original Article

Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)

Ming-Lun Yeh, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Chi-Yi Chen, Hsing-Tao Kuo, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Chi‐Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Pei-Chien Tsai, Cheng-Yuan Peng, Chun-Jen Liu, Ming-Lung Yu

Original Article

Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice

Aiting Yang, Xuzhen Yan, Xu Fan, Yiwen Shi, Tao Huang, Weiyu Li, Wei Chen, Jidong Jia, Hong You

First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients

Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, Pei-Chien Tsai, Ming-Lun Yeh, Po-Yau Hsu, Shiu-Feng Huang, Ming-Jong Bair, Nai-Jen Hou, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Chih-Wen Wang, Ming-Yen Hsieh, Shinn-Chern Chen, Zu-Yau Lin, Ming-Lung Yu, Wan-Long Chuang

Open Access Ascites Original Article

The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes

Lukas Hartl, Mathias Jachs, Christopher Desbalmes, Dunja Schaufler, Benedikt Simbrunner, Rafael Paternostro, Philipp Schwabl, David Josef Maria Bauer, Georg Semmler, Bernhard Scheiner, Theresa Bucsics, Ernst Eigenbauer, Rodrig Marculescu, Thomas Szekeres, Markus Peck-Radosavljevic, Stefan Kastl, Michael Trauner, Mattias Mandorfer, Thomas Reiberger

Open Access Lymphoma Original Article

Increased risk of cancer in patients with primary sclerosing cholangitis

Aiva Lundberg Båve, Annika Bergquist, Matteo Bottai, Anna Warnqvist, Erik von Seth, Caroline Nordenvall

Portal Vein Thrombosis Original Article

A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis

Cheng Han Ng, Darren Jun Hao Tan, Kameswara Rishi Yeshayahu Nistala, Nicholas Syn, Jieling Xiao, Eunice Xiang Xuan Tan, Felicia Zuying Woo, Nicholas W. S. Chew, Daniel Q. Huang, Yock Young Dan, Arun J. Sanyal, Mark D. Muthiah

Survival analysis between laparoscopic and open hepatectomy for hepatocellular carcinoma: a meta-analysis based on reconstructed time-to-event data

Qiang Sun, Xiangda Zhang, Xueyi Gong, Zhipeng Hu, Qiao Zhang, Weiming He, Xiaojian Chang, Zemin Hu, Yajin Chen

Metastasis Original Article

Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma

David Wai Meng Tai, Thi Bich Uyen Le, Aldo Prawira, Rebecca Zhi Wen Ho, Hung Huynh

Ultrasound Original Article

Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma

Chih-Horng Wu, Po-Chin Liang, Tung-Hung Su, Ming-Chi Lin, Yu-Hsuan Chang, Tiffany Ting-Fang Shih, Jia-Horng Kao

Liver Cirrhosis Original Article

Volumetric assessment and clinical predictors of cirrhosis in patients undergoing hepatectomy for hepatocellular carcinoma with presumed normal liver function

Takayuki Shimizu, Taku Aoki, Kyung-Hwa Park, Takatsugu Matsumoto, Takayuki Shiraki, Yuhki Sakuraoka, Shozo Mori, Yukihiro Iso, Mitsuru Ishizuka, Keiichi Kubota

Metastasis Original Article

Efficacy of apatinib in patients with sorafenib–transarterial chemoembolization refractory hepatocellular carcinoma: a retrospective study

Yanyan Cao, Tao Ouyang, Fu Xiong, Xuefeng Kan, Lei Chen, Bin Liang, Chuansheng Zheng

Cholangitis Original Article

Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies

Takanori Ito, Masatoshi Ishigami, Takafumi Yamamoto, Kazuyuki Mizuno, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Hiroki Kawashima, Satoshi Yasuda, Hidenori Toyoda, Kenji Yokota, Tetsunari Hase, Naoki Nishio, Osamu Maeda, Masashi Kato, Naozumi Hashimoto, Hideharu Hibi, Yasuhiro Kodera, Michihiko Sone, Yuichi Ando, Masashi Akiyama, Yoshie Shimoyama, Mitsuhiro Fujishiro

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine